Sanofi iAwards Program Initiative

                    Wednesday, June 10, 2015                                                      Zayed 2119A                                     5:00 p.m. Launch / 6:00 p.m. Reception 

Launch Announcement

Sanofi is a leading global healthcare company engaged in the research, development, manufacturing and marketing of innovative therapeutic solutions aimed at improving people’s lives. Sanofi Global R&D is currently developing innovative vaccines and medicines to treat diabetes, cardiovascular disease, rare disease, immune mediated disease, cancer, infectious disease, neurodegenerative disease, and animal health. To continue to bring new and effective medicines to patients, Sanofi is committed to accelerating the translation of innovative academic ideas into breakthrough therapeutic solutions with measurable impact on health outcomes. Towards this goal, Sanofi and John Hopkins School of Medicine are proud to announce a new initiative, the Sanofi Innovation Awards (Sanofi iAwards) program.

The Sanofi iAwards program brings together seven world-class academic institutions and is intended to:

• Provide seed funding for early innovative, translational, cross-disciplinary research ideas in line with Sanofi’s strategic areas of interest
• Build strong relationships and networks with researchers and senior leadership at Sanofi and participating universities to share and problem solve biopharma innovation challenges
• Accelerate the conversion of innovative discoveries to therapeutic solutions

The expected outcome of the Sanofi iAwards initiative is additional sponsored research funding and joint collaboration to support further advancement of the science behind these innovative ideas.

The Sanofi iAwards is Sanofi’s latest initiative towards building a stronger relationship with academia around specific projects and is designed to leverage the complementary expertise of academia and industry by bringing our individual strengths together towards translating science and technology innovations into new potential therapies for patients.